SARCOMA

Latest News

Tigilanol Tiglate Wins FDA Orphan Drug Designation for Sarcoma
Tigilanol Tiglate Wins FDA Orphan Drug Designation for Sarcoma

February 16th 2024

The FDA has granted an orphan drug designation to tigilanol tiglate for the treatment of soft tissue sarcoma.

FDA Grants Priority Review to BLA of Afami-cel in Synovial Sarcoma
FDA Grants Priority Review to BLA of Afami-cel in Synovial Sarcoma

February 2nd 2024

Need for Systemic Therapy Remains in Sarcoma
Need for Systemic Therapy Remains in Sarcoma

November 27th 2023

INT230-6 Shows Promising Efficacy, Safety in Sarcomas
INT230-6 Shows Promising Efficacy, Safety in Sarcomas

November 2nd 2023

FDA Grants ODD to 3 Ingredients of INT230-6 for Soft Tissue Sarcoma
FDA Grants ODD to 3 Ingredients of INT230-6 for Soft Tissue Sarcoma

September 7th 2023

Latest CME Events & Activities

41st Annual Miami Breast Cancer Conference®

March 7, 2024 - March 10, 2024

Register Now!

Optimizing Pain Management for Breast Cancer Surgery Patients in the Age of the Opioid Epidemic

View More

Community Practice Connections™: What’s Next for Patients with Breast Cancer, and How Can We Effectively Optimize PARP-, HER2/3-, and TROP2-Targeted Regimens in Treatment Plans?

View More

Patient, Provider and Caregiver Connection™: Addressing Patient Concerns During the Treatment and Management of HR+/HER2- Breast Cancer

View More

Oncology Consultations®: Next Generation SERDs—Key Data and Practical Takeaways for the Community Physician

View More

Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

View More

Medical Crossfire®: Leveraging Multidisciplinary Teams in Early–Stage Breast Cancer When the Goal is Cure

View More

23rd Annual International Congress on the Future of Breast Cancer® East

July 19-20, 2024

Register Now!

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

Show Me the Data™: Do We Have Sea Change for Novel Approaches in HR+/HER2- Breast Cancer? CDK, PI3K/AKT, ADC, and Next-Gen SERD Strategies Assessed

View More

Community Practice Connections™: Controversies and Conversations About HER2- Expressing Breast Cancer…Advances in Management of HER2-Low to -Positive Disease

View More

Cancer Summaries and Commentaries™: Clinical Updates from Chicago in Breast Cancer

View More

Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care

View More

Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes

View More

42nd Annual CFS®: Innovative Cancer Therapy for Tomorrow®

November 13-15, 2024

Register Now!

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

More News